The predictive study of the relation between elevated low-density lipoprotein cholesterol to high-density lipoprotein

Tong Lin1,2, Xi Xia1,2, Jing Yu1,2

  • 1Department of Nephrology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 58th, Zhongshan Road II, Guangzhou, 510080, People's Republic of China.

Insights

A high low-density lipoprotein cholesterol to high-density lipoprotein cholesterol (LDL-C/HDL-C) ratio independently predicts increased cardiovascular and all-cause mortality in peritoneal dialysis (PD) patients. This finding highlights the ratio

Area of Science:

  • Nephrology and Cardiovascular Medicine
  • Clinical Epidemiology
  • Biomarker Research

Background:

  • The LDL-C/HDL-C ratio is a recognized cardiovascular risk predictor.
  • Its association with mortality in peritoneal dialysis (PD) patients remains unclear.
  • Understanding this link is crucial for risk stratification in PD populations.

Purpose of the Study:

  • To investigate the predictive value of a high LDL-C/HDL-C ratio for cardiovascular mortality in PD patients.
  • To assess the association between the LDL-C/HDL-C ratio and all-cause mortality in this cohort.

Main Methods:

  • Prospective cohort study of 1616 incident PD patients followed for up to 12 years.
  • Patients categorized into tertiles based on their LDL-C/HDL-C ratio.
  • Cardiovascular mortality and all-cause mortality served as primary and secondary endpoints, respectively.

Main Results:

  • The highest LDL-C/HDL-C ratio tertile was significantly associated with increased CVD mortality (HR: 1.84) and all-cause mortality (HR: 1.35) after multivariate adjustment.
  • Elevated CVD mortality risk was observed in subgroups including females, younger patients (<65 years), those without malnutrition, and patients with diabetes or prior CVD.
  • A median follow-up of 47.6 months revealed 492 deaths, with 50% attributed to cardiovascular disease.

Conclusions:

  • A high LDL-C/HDL-C ratio is an independent predictor of both cardiovascular and all-cause mortality in patients undergoing PD.
  • This lipid ratio can serve as a valuable prognostic marker in the PD population.
Abstract

Related Concept Videos

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
360
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
119
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
510
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
275
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
282
Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
1.7K